SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is trending due to its transformative AI infrastructure partnership with Anthropic and Fluidstack, which includes a substantial data center lease agreement backed by Google. The community views this as a pivotal move, shifting Hut 8 from a Bitcoin miner to a key player in the high-demand AI/HPC sector, offering significant revenue visibility and strategic advantage in the evolving compute market.

Power & Digital Infrastructure Acquisition Corp. operates as a blank check company. The firm engages in seeking a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on December 29, 2020 and is headquartered in Chicago, IL.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending amidst recent analyst upgrades highlighting its robust growth prospects and strategic pivot to high-performance computing infrastructure, fueling investor optimism. However, community discussion is sharply divided following the failed CoreWeave acquisition, with bulls seeing substantial upside in its power assets for AI hosting, while bears voice strong concerns over alleged data center delivery delays and management's execution. This divergence sparks active debate and significant options trading as the market evaluates its potential as a key AI infrastructure provider.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as its FDA approval for YARTEMLEA, the first and only treatment for a rare transplant complication, ignites significant investor enthusiasm. Long-term holders and the broader community see substantial upside, fueled by expectations of multi-billion dollar revenue, a robust financial position from the Novo Nordisk deal, and hopes for a short squeeze or potential acquisition.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is trending due to the anticipation of its upcoming Fusaka Upgrade, poised to enhance network scalability and efficiency. The community is actively debating its potential as a "digital bond" and the foundational "digital oil" for Web3, drawing significant institutional interest and corporate accumulation. This growing embrace of Ethereum's infrastructure for real-world asset tokenization suggests a fundamental shift in digital finance, despite recent market volatility.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending due to heightened U.S. government focus on domestic biotechnology infrastructure, driven by initiatives like the Biosecure Act which impacts foreign competitors and Project Genesis for AI-driven science. The community is actively debating its potential as a critical platform at the intersection of AI and synthetic biology, drawing comparisons to early Palantir given institutional accumulation and strategic partnerships. Investors are weighing its long-term strategic positioning to capture federal and biopharma contracts against the need for strong operational execution.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is generating significant buzz due to the highly anticipated Atopic Dermatitis data release and presentation at the JP Morgan Healthcare Conference in January. The community is optimistic about soquelitinib's potential as a best-in-class oral ITK inhibitor for both autoimmune and oncology indications, with many anticipating substantial price appreciation. Speculation around potential partnerships or acquisition interest is also fueled by a recent strategic board appointment from a major pharmaceutical company and increasing institutional holdings.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is actively discussed as investors navigate robust Q3 GDP data, which is recalibrating expectations for potential Fed rate cuts in 2026, against lingering concerns about the broader market's stability. Community sentiment is mixed, debating whether current resilience points to a sustained Santa Claus rally or an impending correction, with many noting DIA's industrial focus as a potential area of relative strength amid volatility in the tech sector.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a focal point in the highly competitive weight-loss drug market, driven by recent impressive trial results for its next-generation obesity therapies. The community is actively discussing LLY's strategic advancements, including its oral GLP-1 treatment nearing market and substantial manufacturing investments, while also navigating intensified competition from rival oral treatments. Investors are closely assessing LLY's robust pipeline and long-term market leadership as the landscape rapidly evolves.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. ($QBTS) is experiencing a surge in attention, driven by anticipation for its upcoming showcases at CES 2026 and Qubits26, where the company plans to demonstrate its commercial quantum computing solutions and real-world applications. This has sparked bullish excitement around D-Wave's technological edge and potential for major partnerships, with many discussing its "quantum supremacy" and future growth, while skeptics warn of an overvalued "pump and dump" given concerns about its current revenue and executive stock sales.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

ATOM is trending as the Cosmos community actively discusses a proposed tokenomics redesign to shift from inflationary rewards to a revenue-based model, aiming to enhance long-term value. This comes amid divided sentiment, with many expressing frustration over past price performance and comparing it to other high-throughput chains, while proponents highlight robust ecosystem adoption for real-world assets and major integrations as key drivers for future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
